Goto, M., Furuta, S., Yamashita, S., Hashimoto, H., Yano, W., Inoue, N., . . . Kaku, K. (2018). Dipeptidyl peptidase 4 inhibitor anagliptin ameliorates hypercholesterolemia in hypercholesterolemic mice through inhibition of intestinal cholesterol transport. J Diabetes Investig.
Chicago Style citaatGoto, Moritaka, Shinji Furuta, Satoko Yamashita, Hiroyuki Hashimoto, Wataru Yano, Noriyuki Inoue, Noriaki Kato, en Kohei Kaku. "Dipeptidyl Peptidase 4 Inhibitor Anagliptin Ameliorates Hypercholesterolemia in Hypercholesterolemic Mice Through Inhibition of Intestinal Cholesterol Transport." J Diabetes Investig 2018.
MLA citatieGoto, Moritaka, et al. "Dipeptidyl Peptidase 4 Inhibitor Anagliptin Ameliorates Hypercholesterolemia in Hypercholesterolemic Mice Through Inhibition of Intestinal Cholesterol Transport." J Diabetes Investig 2018.